Trials / Completed
CompletedNCT01659827
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
A Prospective, Randomized, Blinded, Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- MiMedx Group, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the AmnioFix Injectable human amniotic membrane is effective in the treatment of recalcitrant plantar fasciitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Marcaine | Injection of 2cc of Marcaine |
| OTHER | 0.5cc AmnioFix | Injection of 0.5cc of AmnioFix Injectable |
| OTHER | 1.25cc AmnioFix | Injection of 1.25cc of AmnioFix Injectable |
| OTHER | Saline | Injection of 1.25cc of Saline |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2012-08-08
- Last updated
- 2013-12-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01659827. Inclusion in this directory is not an endorsement.